NewGenIvf Group Ltd is a diversified health and technology-focused company headquartered in Bangkok, Thailand, and founded in 2019. The company’s core business centers on assisted reproductive services across the Asia-Pacific region and selected international markets. Through its clinics and partner facilities, NewGenIvf Group Ltd provides in vitro fertilization (IVF) treatments, including traditional IVF, ICSI procedures, embryo culture, and related laboratory testing such as hormonal and infectious disease screening and chromosome analysis. It also offers egg donation, surrogacy referral, and ancillary caring services, which may include medical monitoring, nutritional guidance, and other support for intended parents and surrogate mothers. Beyond reproductive health, NewGenIvf Group Ltd operates business divisions involved in real estate development and digital asset-related activities, positioning itself as a tech-forward, multi-jurisdictional platform. The company serves individuals and couples seeking fertility solutions, as well as institutional and commercial partners engaged with its broader real estate and digital asset operations in markets including Thailand, Cambodia, Hong Kong, Kyrgyzstan, China, and the United States.